Eximo Medical

Hybrid Catheters for Interventional Procedures

Health Tech & Life Sciences
Acquired by AngioDynamics
Acquired Rehovot Founded 2012
Total raised
$2.5M
Last: Series A 2015-07
Stage
Acquired
Founded
2012
Headcount
11
HQ
Rehovot
Sector
Health Tech & Life Sciences

About

Eximo Medical is developing hybrid catheter technology for tissue resection in vascular and gastrointestinal endoluminal applications. The companys proprietary single-use hybrid catheter, Auryon, combines optical fibers that deliver short laser pulses and a blunt mechanical knife. The Auryon system is designed to allow treatment of infrainguinal lesions both above and below the knee (including below the ankle), with a built-in off-centering mechanism for eccentric lesions in the largest catheter. The device includes built-in aspiration to address the risk of embolization. Auryon has been tested in a multinational trial in both office-based labs and hospitals.

Funding history · 2 rounds · $2.5M total

2015-07
Series A $1.6M
2012-10
Seed $921K

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was Eximo Medical founded?
Eximo Medical was founded in July 2012.
What is Eximo Medical's primary product?
Eximo Medical's primary product is Auryon, a proprietary single-use hybrid catheter system that combines optical fibers for laser pulses and a blunt mechanical knife for tissue resection.
When was Eximo Medical acquired and by whom?
Eximo Medical was acquired by AngioDynamics in October 2019 for $46,000,000.
What was Eximo Medical's last known funding round?
Eximo Medical's last known funding round was a Series A in July 2015, raising $1,600,000. Investors included Accelmed and AMIT-Technion.
What is the total amount of funding Eximo Medical raised before its acquisition?
Eximo Medical raised a total of $2,521,000 across its funding rounds.
When did Eximo Medical announce the first commercial case of its B-Laser™ Atherectomy System in the U.S.?
Eximo Medical Ltd. announced the first commercial case of its B-Laser™ Atherectomy System in the U.S. in January 2019.
What significant regulatory clearance did Eximo Medical receive in October 2018?
In October 2018, Eximo Medical's B-Laser, the first 355nm laser for peripheral artery disease, received clearance from the FDA.
Where is Eximo Medical's headquarters located?
Eximo Medical's headquarters is located in Rehovot, Israel, with an additional office in Saddle Brook, New Jersey, USA.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Semiconductors & Electronics
Target customers
Healthcare & Life SciencesHealthcareProvidersMedical Devices IndustryMedical Equipment
Business model
B2B

Highlights

1 Patents

Tags

cathetersgastroenterologyvascularlaserssurgerymedical-deviceshealthcare-providersclinicsdoctorscardiologyhospitals